[HTML][HTML] Integrins in cancer: Emerging mechanisms and therapeutic opportunities

F Liu, Q Wu, Z Dong, K Liu - Pharmacology & therapeutics, 2023 - Elsevier
Integrins are vital surface adhesion receptors that mediate interactions between the
extracellular matrix (ECM) and cells and are essential for cell migration and the …

Focal adhesion kinase: from biological functions to therapeutic strategies

X Tan, Y Yan, B Song, S Zhu, Q Mei, K Wu - Experimental Hematology & …, 2023 - Springer
Focal adhesion kinase (FAK), a nonreceptor cytoplasmic tyrosine kinase, is a vital
participant in primary cellular functions, such as proliferation, survival, migration, and …

Barriers and opportunities for gemcitabine in pancreatic cancer therapy

AK Beutel, CJ Halbrook - American Journal of Physiology …, 2023 - journals.physiology.org
Pancreatic ductal adenocarcinoma (PDA) has become one of the leading causes of cancer-
related deaths across the world. A lack of durable responses to standard-of-care …

Roles and inhibitors of FAK in cancer: current advances and future directions

HH Hu, SQ Wang, HL Shang, HF Lv… - Frontiers in …, 2024 - frontiersin.org
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that exhibits high expression
in various tumors and is associated with a poor prognosis. FAK activation promotes tumor …

[HTML][HTML] GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer

C Pecoraro, B Faggion, B Balboni, D Carbone… - Drug Resistance …, 2021 - Elsevier
Pancreatic cancer is an aggressive malignancy with increasing incidence and poor
prognosis due to its late diagnosis and intrinsic chemoresistance. Most pancreatic cancer …

Functional and clinical characteristics of focal adhesion kinases in cancer progression

Z Zhang, J Li, S Jiao, G Han, J Zhu… - Frontiers in Cell and …, 2022 - frontiersin.org
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and an adaptor protein that
primarily regulates adhesion signaling and cell migration. FAK promotes cell survival in …

Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance

J Gonzalez-Molina, L Moyano-Galceran… - Seminars in Cancer …, 2022 - Elsevier
The development of most solid cancers, including pancreatic, breast, lung, liver, and ovarian
cancer, involves a desmoplastic reaction: a process of major remodeling of the extracellular …

HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2

W Feng, J Chen, W Huang, G Wang, X Chen… - …, 2023 - pmc.ncbi.nlm.nih.gov
Background: Metastasis is a major cause of HCC-related deaths with no effective
pharmacotherapies. Chronic inflammation promotes HCC dissemination, however, its …

Breaking the stromal barrier in pancreatic cancer: Advances and challenges

M Chakkera, JB Foote, B Farran… - Biochimica et Biophysica …, 2024 - Elsevier
Pancreatic cancer (PC) remains a leading cause of mortality worldwide due to the absence
of early detection methods and the low success rates of traditional therapeutic strategies …

Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: synthesis …

C Pecoraro, D Carbone, F Scianò… - Journal of Drug …, 2024 - Taylor & Francis
Abstract Focal Adhesion Kinase (FAK) is a non-receptor protein tyrosine kinase that plays a
crucial role in various oncogenic processes related to cell adhesion, migration, proliferation …